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Abstract GM1 ganglioside carrying a fluorescent fatty acid in
substitution of the natural one, has been administered to cultured
Madin-Darby canine kidney (MDCK) cells for different pulse
times (0.5^24 h), and its metabolic fate was followed. The
fluorescent GM2, asialo-GM2, asialo-GM1 and ceramide were
the only detectable metabolites. The complete absence of
fluorescent GM3 is consistent with the presence in these cells
of a sialidase working on GM1 and GM2 gangliosides. After
treatment of the cells with chloroquine the fluorescent GM1
remained essentially undegraded, indicating a catabolic proces-
sing at lysosomal level.
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1. Introduction
The monosialogangliosides GM1 and GM2 are known to
be resistant to the action of most sialidases [1^3]. The occur-
rence of a sialidase activity on GM2 was reported in Tay-
Sachs patients [4,5] and in di¡erent rat [6,7] and mouse [8]
tissues. However, in all the reported cases the ganglioside
GM2 was preferentially converted into GM3, GM2Casialo-
GM2 being a minor pathway.
Recently, Riboni et al. [9] have established that the major
degradation pathway of GM1 in the neurotumoral cell line
Neuro2a is: GM1CGM2Casialo-GM2CLac-CerCGlc-
CerCCer.
During a study on ganglioside transport in polarized Mad-
in-Darby canine kidney (MDCK) cells, we observed that the
£uorescent GM2 derived from administered GM1 was com-
pletely converted to asialo-GM2. In the meantime asialo-
GM1 was a minor catabolite, indicating that in this cell line
the predominant degradative pathway is also determined by a
sialidase acting on ganglioside GM2.
2. Materials and methods
2.1. Chemicals
Minimum essential medium with Earl’s salts (MEM), fetal bovine
serum (FBS; heat inactivated before use) and glutamine were from
Life Technology (Gibco, Milan, Italy). Arthrobacter ureafaciens sialid-
ase (EC 3.2.1.18) was from Calbiochem (Inalco, Milan, Italy), bovine
testes L-galactosidase (EC 3.2.1.23) was from Boehringer (Mannheim,
Germany) and recombinant L-N-acetyl-hexosaminidase (EC 3.2.1.52)
was from Biolabs (Celbio, Pero, Italy). Solvents and miscellaneous
reagents, TLC aluminium sheets silica gel 60 were from Merck
(Darmstadt, Germany). N-Lissamine rhodaminyl-(12-aminododeca-
noyl) GM1 and GM2 (C12-LRh-GM1 and C12-LRh-GM2) were
synthesized as reported for sulforhodamine GM1 and sulforhodamine
GM2 [10]. Standard £uorescent asialo-GM1 and asialo-GM2 were
prepared from the corresponding gangliosides by A. ureafaciens sialid-
ase treatment [11]. Glucosyl-ceramide and ceramide, both containing
the LRh £uorophore, have been obtained following the general syn-
thetic scheme reported for the LRh-sulfatide [12]. LRh-lactosyl-cer-
amide was prepared from the corresponding £uorescent asialo-GM2
by L-N-acetyl-hexosaminidase treatment. Typically, in a ¢nal volume
of 100 Wl, 50 pmol of asialo-GM2 were incubated at 37‡C for 4 h in
the presence of 10 mU of enzyme, 0.29 mM Na-taurodeoxycholate in
10 mM sodium-citrate bu¡er, pH 4.2. All the above analogues have
also been prepared containing the £uorophore BODIPY. In this case
the lyso-derivative of sphingolipid has been reacylated by means of
4,4-di£uoro-5,7-dimethyl-4-bora-3a,4a-diaza-S-indacene-3-dodecanoic
acid (BODIPY0FLC12, Molecular Probes, Eugene, OR, USA) acti-
vated as N-hydroxysuccinimide ester according to Marchesini et al.
[12].
2.2. Cell culture and incubation with C12-LRh-GM1
Madin-Darby canine kidney (MDCK) cells were cultured in MEM
containing 10% FBS and 4 mM glutamine. Con£uent cells (1^1.5 mg
of total protein) were pulsed for 0.5^24 h in MEM containing 1%
FBS, 4 mM glutamine and 5 WM C12-LRh-GM1. At the end of the
pulse cells were scraped o¡ the plates, centrifuged and lyophilized.
2.3. Analysis of the £uorescent lipids
Fluorescent lipids were extracted from lyophilized cells with chloro-
form/methanol (60:40 by volume). Aliquots were taken to quantify
cell-associated £uorescence. Fluorescent lipids were separated on TLC
(aluminium sheets silica gel 60) using ethyl acetate/butanol/chloro-
form/methanol/0.25% KCl (25:25:25:16:9 by volume). Individual
spots were scraped o¡ the plates, extracted from the gel in chloro-
form/methanol/water (5:5:1 by volume) and dried under a nitrogen
stream. Their £uorescence intensities were read in chloroform/meth-
anol (6:4 by volume) on a Jasco FP770 spectro£uorometer using
excitation and emission wavelengths of 565 and 575 nm, respectively.
2.4. Identi¢cation of the metabolites LRh-asialo-GM1 and
LRh-asialo-GM2
The extracts obtained from cells incubated for 24 h in the presence
of LRh-GM1 were analyzed for £uorescent lipids content. After TLC
separation, the spots co-migrating with standard LRh-asialo-GM1
and LRh-asialo-GM2 were isolated, subjected to mild acid hydrolysis
[9] and treated either with L-galactosidase or with L-hexosaminidase
[13].
3. Results
When MDCK cells were pulsed with C12-LRh-GM1, the
GM1 uptake as well as the production of £uorescent metab-
olites were time-dependent. The only £uorescent ganglioside
present at any time was C12-LRh-GM2 (Fig. 1 and Table 1);
no C12-LRh-GM3 was detectable even at incubation times
longer than 24 h. After incubation with C12-LRh-GM2, again
no GM3 was present within an 8-h pulse (Table 1).
Among the non-gangliosidic metabolites, ceramide and two
other £uorescent compounds were detected. The ¢rst detect-
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able product, comigrating on TLC with £uorescent standard
asialo-GM2, gave rise to £uorescent Lac-Cer when subjected
to L-hexosaminidase treatment (Fig. 2). The minor one, de-
tectable in traces at 24 h pulse, comigrating with standard
£uorescent asialo-GM1, was transformed into asialo-GM2
by action of L-galactosidase (Fig. 3). Mild acid hydrolysis
generated Lac-Cer and Glc-Cer from asialo-GM2; Lac-Cer,
Glc-Cer and asialo-GM2 from asialo-GM1 (Fig. 4). Ceramide
was the major compound present at 24 h pulse.
When MDCK cells were incubated with £uorescent C12-
LRh-GM1 in the presence of 50 WM chloroquine, no £uores-
cent metabolites were present into the cells.
Pulse experiments using BODIPY-GM1 gave results qual-
itatively very close to those obtained with LRh-GM1 (data
not shown).
4. Discussion
In this study we have administered £uorescent monosialo-
ganglioside (i.e. N-lissamine rhodamine and BODIPY con-
taining GM1) to MDCK cells and studied its intracellular
metabolism. Already at 0.5 h pulse GM2 is produced, but
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Fig. 1. MDCK cells were pulsed with C12-LRh-GM1 (5 WM) for
0.5, 1, 4, 8 and 24 h (lanes 3, 4, 5, 6 and 7, respectively). TLC sol-
vent system: ethyl acetate/butanol/chloroform/methanol/0.25% KCl
(25:25:25:16:9 by volume). Lane 1, standard LRh-GM1; lane 2,
standard LRh-GM2; lane 8, standard LRh-asialo-GM1, LRh-asia-
lo-GM2, LRh-LacCer, LRh-GLcCer and LRh-Cer (from bottom to
top).
Table 1
Quantitative analysis of metabolites produced after administration of C12-LRh-GM1 or C12-LRh-GM2 to MDCK cells
Administered ganglioside
C12-LRh-GM1 C12-LRh-GM2
Pulse (h) 0.5 1 4 8 24 8
Total cell-associated £uorescence 0.482 0.537 0.949 1.193 2.088 0.749
0.518 0.575 1.013 1.374 2.338 0.851
Total metabolites 0.028 0.055 0.286 0.639 1.602 0.015
0.046 0.093 0.355 0.765 2.013 0.029
Gangliosides
GM2 0.028 0.055 0.253 0.556 1.392 0.734
0.046 0.093 0.313 0.668 1.777 0.822
GM3 N.D. N.D. N.D. N.D. N.D. N.D.
N.D. N.D. N.D. N.D. N.D. N.D.
Other lipids
Asialo-GM1 N.D. N.D. N.D. N.D. 0.019 N.D.
N.D. N.D. N.D. N.D. 0.023 N.D.
Asialo-GM2 N.D. N.D. 0.033 0.042 0.092 0.015
N.D. N.D. 0.042 0.048 0.100 0.029
Cer N.D. N.D. N.D. 0.041 0.099 N.D.
N.D. N.D. N.D. 0.049 0.113 N.D.
Individual £uorescent spots, separated by TLC, were scraped o¡ the plates, extracted with chloroform/methanol/water (5:5:1 by volume) and
spectro£uorometrically quanti¢ed. Total and individual metabolites are expressed as nmol/mg of protein. Data are from two independent experi-
ments.
Fig. 2. L-Hexosaminidase treatment of the asialo-GM2 produced by
MDCK cells. Zero time (lane 3) and after 4 h (lane 4). TLC solvent
system as in Fig. 1. Lane 1, standard LRh-asialo-GM1; lane 2,
standard LRh-asialo-GM2; lane 5, standard LRh-LacCer; lane 6,
standard LRh-GlcCer; lane 7, standard LRh-Cer.
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no asialo-GM1 is detectable. GM2 is mainly degraded to
asialo-GM2. At 24 h pulse, when GM2 represents 87% of
total cell £uorescence, asialo-GM1 is detectable as minor
component whereas GM3 is undetectable. Therefore the pre-
dominant pathway of GM1 degradation in MDCK cells ap-
pears to be the following: GM1CGM2Casialo-
GM2CCCCer. The pathway through asialo-GM1 is a mi-
nor one, whereas the degradation pathway via GM3, which is
the major degradation pathway in normal mammalian cells
[3], is silent in these cells. No £uorescent Lac-Cer and Glc-Cer
were detected after administration of either C12-LRh-GM1 or
C12-BODIPY-GM1, even at the shortest time investigated,
thus indicating their rapid conversion to ceramide.
Although the degradation routes of GM1 observed in
MDCK cells closely resemble those described in Neuro2a cells
[9], it should be noticed that our results have been obtained
using analogues of GM1 ganglioside carrying bulky £uoro-
phores which could alter the £ow rates of the ganglioside
molecules along the di¡erent degradation pathways.
Sialidase activity toward GM1 and GM2 is presumably
located at lysosomal level, being abolished under conditions
which are known to block the activity of lysosomal enzymes.
The conclusion of the present investigation is that MDCK
cells present a sialidase activity on GM1 and GM2 ganglio-
sides as do the neurotumoral Neuro2a cells [9] and PC12 cells,
another cell type of tumoral nature (our data, not published).
The hypothesis [9] that the expression of this sialidase activity
could be linked to the tumoral nature of the cell-line, seems
now more probable, but still remains to be demonstrated.
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Fig. 3. L-Galactosidase treatment of the asialo-GM2 produced by
MDCK cells. Zero time (lane 3) and after 4 h (lane 4). TLC solvent
system as in Fig. 1. Lane 1, standard LRh-asialo-GM1; lane 2,
standard LRh-asialo-GM2; lane 5, standard LRh-LacCer; lane 6,
standard LRh-GlcCer; lane 7, standard LRh-Cer.
Fig. 4. TLC analysis of C12-LRh-asialo-GM1 (lane 3) and C12-
LRh-asialo-GM2 (lane 4) isolated from MDCK cells and subjected
to mild acid hydrolysis. TLC solvent system as in Fig. 1. Lane 1,
standard LRh-asialo-GM1; lane 2, standard LRh-asialo-GM2; lane
5, standard LRh-LacCer; lane 6, standard LRh-GlcCer; lane 7,
standard LRh-Cer.
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